MICROSENS

Microsens Diagnostics (MD) was established to exploit an established technology and patent portfolio in the field of diagnostics. The technology fulfils an unmet need in the development of point of care tests and automated sample extraction methods. MD has an initial focus and extensive collaborations with commercial partners on tuberculosis and MRSA. Sales of the MD technology into the TB market (marketed as TB-Beads) have already been made.